Ikena Oncology Inc.

AI Score

0

Unlock

1.48
-0.03 (-1.99%)
At close: Jan 15, 2025, 11:45 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -68.17M -68.77M -34.12M -44.26M -16.82M -40.87M
Depreciation & Amortization 1.02M 751.00K 544.00K 300.00K 243.00K 422.00K
Stock-Based Compensation 7.63M 7.53M 5.18M 1.80M 1.17M 314.00K
Other Working Capital -18.80M -14.56M -33.39M -8.29M 64.78M -544.00K
Other Non-Cash Items 1.44M 1.52M 1.17M 12.10M -121.00K 29.02M
Deferred Income Tax n/a n/a n/a n/a n/a n/a
Change in Working Capital -21.67M -15.14M -33.03M -7.77M 63.45M 58.00K
Operating Cash Flow -79.74M -74.11M -60.25M -37.83M 47.93M -11.61M
Capital Expenditures -414.00K -1.43M -1.76M -766.00K -316.00K -305.00K
Acquisitions n/a 97.85M n/a 3.69M n/a 11.27M
Purchase of Investments -90.05M -216.34M n/a n/a n/a n/a
Sales Maturities Of Investments 154.61M 118.48M n/a n/a n/a n/a
Other Investing Acitivies n/a -97.85M -1.77M 3.69M n/a 11.27M
Investing Cash Flow 64.14M -99.28M -1.76M 2.92M -316.00K 10.97M
Debt Repayment n/a n/a n/a n/a n/a n/a
Common Stock Repurchased -663.00K n/a n/a -57.00K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 39.22M 1.09M 436.00K 116.24M 16.32M n/a
Financial Cash Flow 75.98M 1.09M 131.74M 116.18M 16.32M n/a
Net Cash Flow 60.38M -172.30M 69.73M 81.28M 63.93M -639.00K
Free Cash Flow -80.16M -75.54M -62.01M -38.59M 47.61M -11.91M